Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Reyes-Acevedo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 10, 2006
[Ethics in organ transplantation: continous search for defining what is acceptable]Rafael Reyes-Acevedo
Clinical Transplantation|September 18, 2009
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony studyUlrich Frei, Pierre Daloze, Stefan Vítko, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 17, 2011
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetesLionel Rostaing, Hans H Neumayer, Rafael Reyes-Acevedo, et al.
Transplantation|November 20, 2010
An integrated safety profile analysis of belatacept in kidney transplant recipientsJosep Grinyó, Bernard Charpentier, José Medina Pestana, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 22, 2011
[Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival]Elizabeth Hernández-Infante, Cecilia García-Martínez, Sanjuana Beltrán-de-la-Luz, et al.
Transplant Immunology|February 25, 2014
Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatmentJanette Furuzawa-Carballeda, Ian C Bostock, Guadalupe Lima, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|August 25, 2012
[Renal transplantation program at the Centenario Hospital Miguel Hidalgo in Aguascalientes, Mexico]Rafael Reyes-Acevedo, Luis Romo-Franco, Rodolfo Delgadillo-Castañeda, et al.
Clinical Transplantation|November 7, 2019
Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipientsJosé Manuel Arreola-Guerra, Josefina Alberú, Alfredo Chew-Wong, et al.
Transplantation Proceedings|November 10, 2021
Chronic Kidney Disease Risk Profile in Renal Donors in Aguascalientes, Mexico: A Retrospective Cohort StudyAna Lilian Reza-Escalera, Maria Teresa Tiscareño-Gutiérrez, Itzel Ovalle-Robles, et al.
Clinical Kidney Journal|June 7, 2021
High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directionsMauricio Gutierrez-Peña, Leslie Zuñiga-Macias, Ricardo Marin-Garcia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 10, 2006
[Ethics in organ transplantation: continous search for defining what is acceptable]Rafael Reyes-Acevedo
Clinical Transplantation|September 18, 2009
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony studyUlrich Frei, Pierre Daloze, Stefan Vítko, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 17, 2011
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetesLionel Rostaing, Hans H Neumayer, Rafael Reyes-Acevedo, et al.
Transplantation|November 20, 2010
An integrated safety profile analysis of belatacept in kidney transplant recipientsJosep Grinyó, Bernard Charpentier, José Medina Pestana, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 22, 2011
[Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival]Elizabeth Hernández-Infante, Cecilia García-Martínez, Sanjuana Beltrán-de-la-Luz, et al.
Transplant Immunology|February 25, 2014
Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatmentJanette Furuzawa-Carballeda, Ian C Bostock, Guadalupe Lima, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|August 25, 2012
[Renal transplantation program at the Centenario Hospital Miguel Hidalgo in Aguascalientes, Mexico]Rafael Reyes-Acevedo, Luis Romo-Franco, Rodolfo Delgadillo-Castañeda, et al.
Clinical Transplantation|November 7, 2019
Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipientsJosé Manuel Arreola-Guerra, Josefina Alberú, Alfredo Chew-Wong, et al.
Transplantation Proceedings|November 10, 2021
Chronic Kidney Disease Risk Profile in Renal Donors in Aguascalientes, Mexico: A Retrospective Cohort StudyAna Lilian Reza-Escalera, Maria Teresa Tiscareño-Gutiérrez, Itzel Ovalle-Robles, et al.
Clinical Kidney Journal|June 7, 2021
High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directionsMauricio Gutierrez-Peña, Leslie Zuñiga-Macias, Ricardo Marin-Garcia, et al.
Pageof 1